Showing 11,721 - 11,740 results of 66,574 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ( 10 ((nm decrease) OR (mean decrease)) ))', query time: 0.93s Refine Results
  1. 11721
  2. 11722
  3. 11723
  4. 11724
  5. 11725
  6. 11726

    Average relative abundance of the 6 main taxa in undiluted saliva and dilutions 1 to 3 (10<sup>7</sup> to 10<sup>5</sup> bacteria per ml, respectively). by Giske Biesbroek (104538)

    Published 2012
    “…Dilution 3 shows a significant increase in Proteobacteria (p<0.001, mean 26,11% and 3.6%, SD 17.5 and 2.5% respectively) and a significant decrease in Bacteroidetes (p<0.001, mean 18.99% and 43.1% respectively) compared to the undiluted saliva samples. …”
  7. 11727
  8. 11728
  9. 11729

    Heme-mediated stimulation of CXCL10 expression is TLR4 dependent. by Carmen M. Dickinson-Copeland (824626)

    Published 2015
    “…Data reported as mean fold-change relative to GAPDH. (B) CXCL10 expression is TLR4 dependent in supernatants of HBVEC and CD34<sup>+</sup>-HSPC <i>in vitro</i>. …”
  10. 11730
  11. 11731

    Immunoblot expressions of TTR levels in HepG2 cells exposed to low (1.0 µg/mL) and high (10 ug/mL) concentrations of warfarin for 24 hrs. by Ramasamy Saminathan (358756)

    Published 2013
    “…The decrease in expression of TTR was significantly greater in HepG2 cells exposed to higher concentration (10 ug/mL) of warfarin under serum-rich conditions (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0015064#pone-0015064-g004" target="_blank">Fig. 4A</a>; P = 0.01).…”
  12. 11732
  13. 11733
  14. 11734
  15. 11735

    Cell cycle accumulation at G2/M in MTDH knockdown Hec50co cells at 24 hours after LBH589 or LBH589 and TRAIL treatment. by Xiangbing Meng (200278)

    Published 2011
    “…<p>(A) Cell cycle profiles were determined in control or MTDH knockdown Hec50co cells at 24 hours after treatment with 20 nM LBH589, 25 ng/ml TRAIL, or LBH589 and TRAIL in combination. …”
  16. 11736
  17. 11737
  18. 11738

    Discovery of a Potent SARM1 Base-Exchange Inhibitor with In Vivo Efficacy by Maude Giroud (2017114)

    Published 2025
    “…When tested in vivo, compound <b>7</b> showed efficacy after oral dosing in a mouse model of peripheral nerve injury by decreasing plasma neurofilament light (NfL) levels at 50 mg/kg compared with vehicle-treated control mice, holding promise for the treatment of neurodegenerative and neurological disorders.…”
  19. 11739
  20. 11740